MELA Insider Trading Activity and SEC Form 4 Filings
MELA insider trading summary
No open-market insider purchases or sales of Mela Sciences, Inc. (MELA) have been reported on SEC Form 4 in the past 12 months.
Latest MELA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 31, 2014 | Robert W. Cook | Chief Financial Officer | Buy | $12K (10,000 @ $1.23) |
| May 22, 2014 | Anthony J Dimun | Director | Buy | $10K (26,250 @ $0.38) |
| May 22, 2014 | Anthony J Dimun | Director | Buy | $13K (35,000 @ $0.38) |
| May 22, 2014 | Anthony J Dimun | Director | Buy | $10K (26,250 @ $0.38) |
| Feb 5, 2014 | Kathryn B Swintek | Director | Buy | $10K (13,513 @ $0.74) |
| Feb 5, 2014 | Rosemary A Crane | CEO and President | Buy | $50K (67,570 @ $0.74) |
| Feb 5, 2014 | Anthony J Dimun | Director | Buy | $10K (13,513 @ $0.74) |
| Feb 5, 2014 | David K Stone | Director | Buy | $10K (13,514 @ $0.74) |
| Feb 5, 2014 | Robert Coradini | Chairman | Buy | $50K (67,567 @ $0.74) |
| Feb 5, 2014 | LuAnn Via | Director | Buy | $10K (13,513 @ $0.74) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.